Search

Learn how Danielle has faced hereditary breast cancer caused by a BRCA1 gene mutation and had fewer side effects than traditional chemotherapy because of an experimental treatment at MSK.

… Thursday, October 5, 2023 In March 2023, Danielle Polumbo found a lump in her breast. “It shook me to my core,” the 28-year-old remembers. “I knew right away that this was not good.” Just 18 months earlier, Danielle had learned that she carried a mutation in the BRCA1 gene , which greatly increases risk

Learn more about how the keto diet may one day be used as a boost to cancer treatment.

… Tuesday, May 11, 2021 The ketogenic, or “keto,” diet may have benefits beyond a whittled waistline. The low-carbohydrate, high-fat diet that helps your body to use fat as fuel may also be beneficial in the fight against cancer. Memorial Sloan Kettering medical oncologist Vicky Makker is studying the

MSK experts have conducted the first large-scale study focused specifically on burnout among practicing anesthesiologists in the United States.

… Monday, April 19, 2021 MSK anesthesiologist Anoushka Afonso, MD , and Joshua Cadwell, GME medical student summer fellowship program alumni, partnered with colleagues from Boston Children’s Hospital and Harvard Medical School, to conduct the first large-scale study focused specifically on burnout among

To recognize the beginning of Breast Cancer Awareness Month, MSK shared five tips to help women navigate the prevention, diagnosis, and treatment of breast cancer during the COVID-19 global health crisis.

… Wednesday, September 30, 2020 Dr. Larry Norton Dr. Larry Norton To recognize the beginning of Breast Cancer Awareness Month, Memorial Sloan Kettering Cancer Center (MSK) today shared five tips to help women navigate the prevention, diagnosis, and treatment of breast cancer during the COVID-19 global

Para destacar el inicio del Mes de Concientización del Cáncer de Mama, MSK compartió cinco consejos para ayudar a las mujeres a manejar la prevención, el diagnóstico y el tratamiento del cáncer de mama durante la crisis de salud mundial ocasionada por el COVID-19.

… Wednesday, September 30, 2020 Dr. Larry Norton Dr. Larry Norton Para destacar el inicio del Mes de Concientización del Cáncer de Mama, Memorial Sloan Kettering Cancer Center (MSK) compartió cinco consejos para ayudar a las mujeres a manejar la prevención, el diagnóstico y el tratamiento del cáncer de

MSK researchers have found that a protein that contributes to one type of leukemia when it’s missing can lead to the formation of a different leukemia type when it’s present.

… Wednesday, November 21, 2018 Summary MSK researchers have found that Helios — a protein named after the Greek sun god — contributes to one type of leukemia when it’s missing but can lead to the formation of a different leukemia type when it’s present. Proteins are one of the fundamental building blocks

… Wednesday, November 24, 2021 Updates 9/2/25: Dr. Bott, pathologist Marina Baine, MD, PhD , and i nterventional pulmonologist Or Kalchiem-Dekel, MD , recently led the first study to evaluate the yield and accuracy of ssRAB-obtained biopsy specimens across all stages of lung cancer. The retrospective review

Learn how to manage menopause symptoms if you have breast cancer

… Friday, October 28, 2016 Summary The menopause symptoms that can sometimes happen as a result of breast cancer treatment are an unwelcome side effect. Memorial Sloan Kettering medical oncologist Shari Goldfarb shares her recommendations for how women can find relief. Highlights Women with breast cancer

Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.

… Monday, August 3, 2020 Summary A large international study led by researchers at Memorial Sloan Kettering has immediate clinical relevance for risk assessment and treatment of people with myelodysplastic syndrome and acute myeloid leukemia. Considered the “guardian of the genome,” TP53 is the most commonly

An uptick in colorectal cancer in people under the age of 50 is an alarming trend that led Memorial Sloan Kettering to develop the first of its kind Center for Young Onset Colorectal Cancer in 2018. Read more.

… Monday, August 31, 2020 VIDEO | 01:05 Learn More about MSK's Center for Young Onset Colorectal Cancer Gastroenterologist Robin Mendelsohn explains how young people with colorectal cancer are treated at MSK. She also discusses ongoing research into the causes of young onset colorectal cancer. Video Details